左心室辅助装置植入后未矫正三尖瓣反流的临床影响与自然病程:EUROMACS注册分析
基于EUROMACS注册数据,纳入2496例无同期三尖瓣手术的成人LVAD植入患者,评估未矫正三尖瓣反流的临床影响与自然病程。结果显示未矫正TR与早期死亡率无直接关联,但通过术前右房压、肌酐和胆红素水平存在间接关联;术后TR与晚期死亡率升高相关,但平均而言TR在LVAD植入后逐渐减轻。
要点
- 未矫正TR与30天死亡率无直接关联,但经术前右房压、肌酐和胆红素介导存在间接关联。
- 平均而言未矫正TR在LVAD植入后逐渐减轻,同期三尖瓣手术选择不应仅基于TR分级。
核心结论
- LVAD植入前和植入后未矫正TR与早期和晚期死亡率升高相关。
- 平均而言,未矫正TR在LVAD植入后无需干预即可逐渐减轻。
- 同期三尖瓣手术的患者选择不应仅基于TR分级。
研究设计与样本
- 基于欧洲机械循环支持患者注册(EUROMACS)的回顾性分析。
- 纳入2496例无同期三尖瓣手术的成人LVAD植入患者,中位年龄56岁,男性占83%。
- 采用中介模型评估TR与30天死亡率的关联,广义混合模型建模术后TR病程,联合模型进行敏感性分析。
主要发现
- TR与30天死亡率无直接关联,但中介分析提示经术前右房压升高和肌酐(P=0.035)及胆红素(P=0.027)水平存在间接关联。
- 术前无至轻度TR患者LVAD植入后即刻发生中至重度TR的概率为10%。
- 术前中至重度TR患者LVAD植入后即刻发生中至重度TR的概率为35%,且无论术前有无右心衰竭或肺动脉高压,该概率持续下降。
临床怎么用
- LVAD植入前应评估TR分级及右心功能相关指标(右房压、肌酐、胆红素)。
- 术后TR与晚期死亡率相关,需关注LVAD植入后TR的随访监测。
- 同期三尖瓣手术决策不应仅依据TR分级,需综合评估其他风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Data on the impact and course of uncorrected tricuspid regurgitation (TR) during left ventricular assist device (LVAD) implantation are scarce and inconsistent. This study explores the clinical impact and natural course of uncorrected TR in patients after LVAD implantation. METHODS: The European Registry for Patients with Mechanical Circulatory Support was used to identify adult patients with LVAD implants without concomitant tricuspid valve surgery. A mediation model was developed to assess the association of TR with 30-day mortality via other risk factors. Generalized mixed models were used to model the course of post-LVAD TR. Joint models were used to perform sensitivity analyses. RESULTS: A total of 2496 procedures were included (median age: 56 years; men: 83%). TR was not directly associated with higher 30-day mortality, but mediation analyses suggested an indirect association via preoperative elevated right atrial pressure and creatinine (P = 0.035) and bilirubin (P = 0.027) levels. Post-LVAD TR was also associated with increased late mortality [hazard ratio 1.16 (1.06-1.3); P = 0.001]. On average, uncorrected TR diminished after LVAD implantation. The probability of having moderate-to-severe TR immediately after an implant in patients with none-to-mild TR pre-LVAD was 10%; in patients with moderate-to-severe TR pre-LVAD, it was 35% and continued to decrease in patients with moderate-to-severe TR pre-LVAD, regardless of pre-LVAD right ventricular failure or pulmonary hypertension. CONCLUSIONS: Uncorrected TR pre-LVAD and post-LVAD is associated with increased early and late mortality. Nevertheless, on average, TR diminishes progressively without intervention after an LVAD implant. Therefore, these data suggest that patient selection for concomitant tricuspid valve surgery should not be based solely on TR grade.
引用
- Veen KM, Mokhles MM, Soliman O, et al. Clinical impact and 'natural' course of uncorrected tricuspid regurgitation after implantation of a left ventricular assist device: an analysis of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). Eur J Cardiothorac Surg. 2021. PMID: 33038216. doi:10.1093/ejcts/ezaa294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。